CCCC

C4 THERAPEUTICS INC

CCCC·12529R107·US·Common Stock·Healthcare - Biotechnology-13D/G

CCCC (C4 THERAPEUTICS INC) is held by 71 institutional investors as of Q1 2026. Largest holders: MORGAN STANLEY ($23.9M), RA CAPITAL MANAGEMENT, L.P. ($21M), VANGUARD CAPITAL MANAGEMENT LLC ($10.2M). Net institutional sentiment: Bullish.

71
Holders
Avg rating(15 Elite)
$148.1M
Total Value
70% (75)
Fund Consensus
46 buying - 20 selling
CCCCSmart Money Verdict
View all
Held by 71 funds
15 elite
Who's Trading
ActivistSMSquadron Master Fund LP5.0%May 19, 2026
ActivistPoint72 Asset Management, L.P.Point72 Asset Management, L.P.0.2%May 15, 2026
ActivistSISirenia Capital Management LP9.9%May 15, 2026
ActivistWasatch Advisors LPWasatch Advisors LP4.7%Apr 22, 2026
ActivistLYLynx1 Capital Management LP7.3%Feb 17, 2026
ActivistOAOrbiMed Advisors LLC0.5%Feb 17, 2026
ActivistSPSoleus Private Equity Fund III, L.P.5.9%Feb 12, 2026
ActivistMorgan StanleyMorgan Stanley9.3%Feb 11, 2026
InsiderRLREYNO LEONARDSell $22KJan 16, 2026
ActivistBLBain Capital Life Sciences Fund II, L.P.1.1%Oct 24, 2025
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
9.1M(+1.0%)$23.9M0.0%+32.84%
29
Unchanged
8M$21M0.2%+107.14%
0
New
3.9M$10.2M0.0%+37.63%
38
Increased
3M(+101.1%)$8M0.0%+18.36%
44
Decreased
3M(-31.8%)$7.8M0.1%-62.06%
0
Increased
3.2M(+541x)$7.6M0.0%+37.61%
44
Increased
2.5M(+460.7%)$6.6M0.0%+43.89%
44
Increased
2.5M(+53.6%)$6.5M0.0%+91.65%
38
Increased
2.4M(+119.2%)$6.3M0.0%+51.75%
44
Decreased
2.4M(-1.2%)$6.2M0.0%+30.38%
0
Increased
2M(+4.0%)$5.4M0.0%+22.78%
28
Increased
1.4M(+17.2%)$3.7M0.0%+103.42%
31
Decreased
1.3M(-27.5%)$3.4M0.0%+95.48%
0
Increased
1.2M(+42.5%)$3.3M0.0%+86.58%
35
Increased
1.1M(+1905.2%)$2.8M0.0%+38.18%
42
Decreased
951,043(-3.8%)$2.5M0.0%-60.59%
0
Increased
867,911(+7.3%)$2.3M0.0%+99.78%
28
New
830,624$2.2M0.0%0.00%
36
Increased
752,114(+159.1%)$2M0.0%+55.58%
42
New
484,131$1.3M0.0%+37.63%
35

Showing 1-20 of 75

1 / 4

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used